SCHEMBL29066264

SCHEMBL29066264

CN(CCNC(=O)OC(C)(C)C)c1ccc(Br)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CKS1B P61024 1/20 0.49
▸ SKP1 P63208 1/20 0.49
▸ SKP2 Q13309 1/20 0.49
▸ FPR3 P25089 5/20 0.44
▸ FPR2 P25090 5/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ HSP90AA1 P07900 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ RECQL P46063 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ SUV39H2 Q9H5I1 2/20 0.43
▸ MALT1 Q9UDY8 1/20 0.41
▸ CTSS P25774 1/20 0.41
▸ CTSK P43235 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ CA12 O43570 2/20 0.40
▸ CA1 P00915 2/20 0.40
▸ CA2 P00918 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30850465 0.86 CKS1B (0.49) CKS1BSKP1SKP2MEN1KMT2A
SCHEMBL1433076 0.84 MAPT (0.49) CKS1BSKP1SKP2FPR3FPR2
SCHEMBL30850514 0.82 MAPT (0.50) CKS1BSKP1SKP2NPC1RAB9A
SCHEMBL24329996 0.81 TMEM97 (0.48) CKS1BSKP1SKP2FPR3FPR2
SCHEMBL1998123 0.78 CKS1B (0.53) CKS1BSKP1SKP2SUV39H2MALT1
SCHEMBL15092378 0.78 AAK1 (0.48) CKS1BSKP1SKP2SUV39H2MALT1
SCHEMBL9100684 0.78 CKS1B (0.52) CKS1BSKP1SKP2MEN1KMT2A
SCHEMBL24257374 0.77 TDP1 (0.48) CKS1BSKP1SKP2MEN1KMT2A
SCHEMBL1065312 0.77 CA2 (0.55) FPR3FPR2NPC1RECQLRAB9A
SCHEMBL31687500 0.76 SIGMAR1 (0.58) FPR3FPR2MEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116723839-A Tricyclic heterobifunctional compounds for degrading target proteins C4医药公司 2023-09-08 — — CN disclosed
Send feedback